Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-09-25

Clinical Trial Update: MitoQ and Ischemic Conditioning To Assess Vascular Health Outcomes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating MitoQ in combination with ischemic conditioning to assess vascular health outcomes in stroke; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MitoQ

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Stroke | Phase 2 | Status: RECRUITING